Portfolio company
Rejuveron
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops medicines and regenerative therapies targeting age-related diseases to improve healthspan for the aging population.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rejuveron Life Sciences
This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.
Rejuveron Life Sciences AG
This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.
RejuverSen
This biotechnology firm develops senolytic therapies to eliminate senescent cells for treating cancer, fibrosis and age-related diseases in humans.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Turn Biotechnologies
This company develops mRNA medicines and delivery platforms for cellular rejuvenation and tissue repair to treat age-related conditions for patients and pharmaceutical partners.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
Juvena Therapeutics
This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.
Rejuvenate Biomed
This biotech company develops AI-enabled prescription combination drugs to treat age-related diseases and muscle decline in older patients.
